![tirzepatide molecular structure Chemical of (MounjaroTM). Blue: Aminoisobutyric Fragment [3-39]-Tirzepatide - Daicel Pharma](https://www.researchgate.net/publication/368654587/figure/fig3/AS:11431281420615529@1746253234334/Chemical-structure-of-Gadopiclenol-EluciremTM-Brown-two-water-molecules-that-show_Q320.jpg)
tirzepatide molecular structure Chemical of (MounjaroTM). Blue: Aminoisobutyric Fragment [3-39]-Tirzepatide - Daicel Pharma
Description
Read more in our blog.
![tirzepatide molecular structure Chemical of (MounjaroTM). Blue: Aminoisobutyric Fragment [3-39]-Tirzepatide - Daicel Pharma](https://www.daicelpharmastandards.com/wp-content/uploads/2024/05/dcti-d-363.png)
How FDAs recent announcement is causing major headaches for makers of compounded GLP-1 products.
![tirzepatide molecular structure Chemical of (MounjaroTM). Blue: Aminoisobutyric Fragment [3-39]-Tirzepatide - Daicel Pharma](https://www.mdpi.com/molecules/molecules-27-04315/article_deploy/html/images/molecules-27-04315-g003.png)
Medical professionals urge caution for the next several days.
![tirzepatide molecular structure Chemical of (MounjaroTM). Blue: Aminoisobutyric Fragment [3-39]-Tirzepatide - Daicel Pharma](https://upload.wikimedia.org/wikipedia/commons/thumb/2/20/Tirzepatide_GLP1R_complex_7rgp.png/250px-Tirzepatide_GLP1R_complex_7rgp.png)
The most interesting reason to pursue glucagon agonism in a multi-receptor agonist is the possibility that you could alter hepatic liver metabolism and potentially decrease fatty acid accumulation and hypertriglyceridemia, said David A
![tirzepatide molecular structure Chemical of (MounjaroTM). Blue: Aminoisobutyric Fragment [3-39]-Tirzepatide - Daicel Pharma](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-28683-0/MediaObjects/41467_2022_28683_Fig2_HTML.png)
